# Mentice

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/mentice).

## Overview

Mentice is a Sweden-based medical technology company focused on simulation and digital training for image-guided interventional therapy. Its business centers on software, hardware, and patient-specific planning tools used to train clinicians and support procedure planning across global healthcare and medical device markets.

## Products & services

• Mentice VIST® simulation platform
• Mentice Live remote learning software
• Physical simulation systems
• Ankyras® patient-specific planning
• AI/VR/AR-enabled training solutions

- **Simulation platforms** (70%) — Software and hardware systems used to simulate interventional procedures for training and proficiency development.
- **Software and remote learning** (15%) — Digital training, remote education, and software-based learning tools for clinicians and device teams.
- **Patient-specific planning** (10%) — Ankyras-based decision-support tools that help plan treatment for specific patients and procedures.
- **Physical simulation and accessories** (5%) — Physical simulation products and related components used in medical training environments.

- Mentice VIST® simulation platform
- Mentice Live remote learning software
- Physical simulation systems
- Ankyras® patient-specific planning
- AI/VR/AR-enabled training solutions

## Customers

Mentice sells to medical device companies, hospitals, healthcare systems, and clinical training organizations that need realistic interventional procedure simulation. It also serves research, education, and physician training users that want to improve procedural proficiency, standardize training, and support treatment planning.

- **Medical device companies** (primary) — Buy simulation systems and software to train sales teams, support product launches, and educate clinicians.
- **Healthcare systems and hospitals** (primary) — Use training platforms and planning tools to improve procedural quality and standardize care.
- **Clinical training and education providers** (secondary) — Purchase simulation tools for physician training, certification, and skills development.
- **Research and innovation teams** (secondary) — Use digital vascular twins and planning software for procedure development and evaluation.

- Medical device companies using simulators for product training and trials
- Hospitals and healthcare systems training interventional teams
- Physicians and clinical educators seeking procedure proficiency tools
- Training centers and universities running simulation-based curricula
- Customers needing patient-specific planning for complex procedures

## Geography

Mentice reports revenue across the Americas, EMEA, and APAC, with the Americas as its largest region. The company has offices and representation in Sweden, the United States, Singapore, Japan, China, India, Brazil, Germany, Spain, and France, which supports global sales, customer support, and market access.

- **Americas** (54%)
- **EMEA** (30%) — Combined region disclosed by the company; country mix not specified.
- **APAC** (16%)

- Americas accounted for 54% of 2025 revenue
- EMEA accounted for 30% of 2025 revenue
- APAC accounted for 16% of 2025 revenue
- Offices and representation span Europe, the US, and Asia
- Global footprint supports device-company and hospital customers

## Strategy

Mentice’s strategy is centered on image-guided interventional therapy education, combining simulation realism with digital tools that improve training and procedure planning. The company is also expanding software-based remote learning and healthcare-system relationships, while using its global footprint and product portfolio to deepen adoption across device companies and clinical customers.

- **Expand IGT education and training solutions** (medium-term) — This is the core market where Mentice differentiates through clinical realism and procedure training.
- **Capture healthcare system network opportunities** (medium-term) — Large hospital networks can scale adoption across many clinicians and sites.
- **Increase software and remote learning mix** (short-term) — Software can broaden reach beyond physical installations and support recurring usage.

- Expand image-guided interventional therapy education offerings
- Grow software-based remote learning alongside simulator sales
- Strengthen healthcare-system relationships in the US
- Use AI, VR/AR, and digital twins to improve product depth
- Broaden customer and geographic diversification

## Risks

Mentice faces customer concentration, IT and hardware reliability risks, and exposure to international currency and geopolitical conditions. Because it sells into regulated healthcare and medical-device environments, changes in customer budgets, supply chains, or local rules can affect delivery timing and demand.

- **Customer concentration** [high] — A limited number of customers contribute a large share of turnover and earnings.
- **IT and hardware disruption** [high] — The business depends on IT systems and hardware to produce and deliver solutions on time.
- **Currency risk** [medium] — Revenue is mainly in USD and EUR while costs are in SEK, USD, and EUR.
- **Supply chain and geopolitical disruption** [medium] — Third-party suppliers and global manufacturing links can be affected by conflict or logistics issues.
- **Regulatory and compliance risk** [medium] — Operating across jurisdictions increases exposure to local rules, anti-corruption, and competition law.

- A few customers account for a large share of turnover and earnings
- IT or hardware outages can disrupt production and customer deliveries
- Currency exposure is significant because revenue and costs are multi-currency
- Supply chain and geopolitical issues can affect simulator manufacturing
- Hiring and retaining skilled staff is important for product development
- Corruption and compliance risk exists across multiple jurisdictions

## Accounting

Mentice’s reporting is affected by revenue recognition on contracts that include hardware, software, and service elements, as well as contract assets and liabilities. The company also uses forward exchange contracts for currency hedging, and its balance sheet includes goodwill and developed intangibles that require ongoing impairment and valuation judgment.

- **Revenue recognition and contract balances** — Agreement assets and liabilities are material on the balance sheet
- **Derivative accounting** — Can create period-to-period volatility in financial income
- **Goodwill and intangible assets** — Write-down risk if expected cash flows weaken
- **Estimates and assumptions** — Reported earnings and balance sheet values can change with revised assumptions

- Revenue recognition across hardware, software, and service bundles
- Contract assets and contract liabilities affect timing of reported sales
- Forward exchange contracts are measured at fair value
- Goodwill and patents require impairment and useful-life judgment
- Internally developed intangibles affect capitalized development costs

---

*Last updated: 2026-08-11T04:04:54.176548+00:00*
